Ardelyx Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 30.97. In total, the insiders bought 4 302 816 and sold 2 075 823 ARDX shares in the last 100 trades.

Insider Power

(Last 100 transactions)
30.97
Buy 4 302 816 Shares
Sell 2 075 823 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 28, 2024 Common Stock Sell Raab Michael 2 310
Jun 21, 2024 Common Stock Sell Blanks Robert 38 000
Jun 14, 2024 Common Stock Buy Rodgers Richard J 12 204
Jun 14, 2024 Stock Option (Right to Buy) Buy Rodgers Richard J 40 243
Jun 14, 2024 Stock Option (Right to Buy) Buy Bhanji Muna 40 243
Jun 14, 2024 Common Stock Buy Bertrand William C Jr 11 023
Jun 14, 2024 Stock Option (Right to Buy) Buy Bertrand William C Jr 40 243
Jun 14, 2024 Stock Option (Right to Buy) Buy Cadoret-manier Onaiza 40 243
Jun 14, 2024 Stock Option (Right to Buy) Buy Bazemore Robert B 40 243
Jun 14, 2024 Common Stock Buy Mott David M 17 322
Jun 14, 2024 Stock Option (Right to Buy) Buy Mott David M 40 243
Jun 13, 2024 Common Stock Buy Raab Michael 35 000
Jun 13, 2024 Common Stock Sell Raab Michael 35 000
Jun 13, 2024 Stock Option (Right to Buy) Sell Raab Michael 35 000
Jun 05, 2024 Common Stock Buy Williams Laura A 100 000
Jun 05, 2024 Common Stock Sell Williams Laura A 45 000
Jun 05, 2024 Common Stock Sell Williams Laura A 100 000
Jun 05, 2024 Stock Option (Right to Buy) Sell Williams Laura A 100 000
Jun 03, 2024 Common Stock Sell Rosenbaum David P. 17 872
May 29, 2024 Common Stock Sell Raab Michael 7 500
May 21, 2024 Common Stock Sell Williams Laura A 4 794
May 21, 2024 Common Stock Sell Rosenbaum David P. 4 855
May 21, 2024 Common Stock Sell Rosenbaum David P. 2 198
May 21, 2024 Common Stock Sell Rodriguez Susan 6 703
May 21, 2024 Common Stock Sell Renz Justin A 5 167
Click to get the best stock tips daily for free!

About Ardelyx

Ardelyx Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial to control serum phosphorus in adult pat... ARDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT